The Advanced Medical Technology Group (AdvaMed), the world’s biggest trade association representing medical device makers, participated in the Biden Administration’s 2022 Global Supply Chain Ministerial to debate important solutions to solve healthcare supply chain disruptions. AdvaMed has participated in and led conversations between the MedTech industry, government officials, and critical suppliers such as semiconductor chip manufacturers as a member of the Administration’s Joint Supply Chain Resilience Working Group, urging all parties to prioritize the health care industry.
The 2021 Global Supply Chain Summit, which brought together international partners to talk about tackling supply network bottlenecks and long-term supply chain resiliency, served as a precursor to the ministerial, which is being co-hosted by the US Departments of State and Commerce. Participants include industry, labor, civil society, and subnational officials, who will participate in four sessions (Crisis Response; Enabling Environment/Investment; Transportation/Logistics; Workforce Development/Labor). The discussions will result in a summary of findings, which will be shared with Secretaries Blinken and Raimondo, as well as their international colleagues.
“AdvaMed is pleased to join other national leaders in addressing supply chain issues affecting the global Medtech sector and the patients we serve,” stated Scott Whitaker, President, and CEO of AdvaMed. “Whether it’s semiconductor chips or medical-grade packaging, these inputs are critical in the production of innumerable life-saving medical devices.” With widespread shortages aggravated by the current pandemic and other global causes, we will face a health catastrophe for millions of patients if we do not prioritize health care to solve both short- and long-term supply chain challenges. We appreciate Secretary Blinken and Secretary Raimondo’s leadership on this topic, as well as organizing this crucial gathering this week.”
“These discussions between government and business leaders are critical to addressing our ongoing supply chain challenges, and we are grateful for the opportunity to engage with stakeholders who share our concerns,” said Abby Pratt, AdvaMed Sr. Vice President and member of the Executive Committee of the Joint Supply Chain Resilience Working Group. “While supply chain disruptions affect every business, a shortage of crucial parts and components for MedTech manufacturers would disrupt health care delivery and threaten our national security.” AdvaMed will continue to work with the federal government and supply chain partners to solve these short- and long-term supply chain concerns, as well as to lobby for health care priorities.”
